Videos

Alan Holmer, prsident and CEO of the Pharmaceutical Research and Manufacturers of America, spoke about prescription drug costs, drug patents, and Medicare prescription drug legislation. He r…

Witnesses testified in front of the Senate Finance Committee about the benefits of providing prescription drug benefits for Medicare recipients. They focused on the increasing cost of develo…

The Senate Finance Committee heard testimony from Japanese academics, and U.S. businessmen and economists. They discussed the consequences of the lack of economic growth in Japan and other A…

The Business Association of Executives met to discuss the upcoming State of the Union address in January. They talked about the business interests they feel should be included in the preside…

Guests discussed the proposed FDA reform legislation and its impact on patients and drug companies.

The Bureau of National Affairs holds a panel discussion focusing on foreign investments in the United States. The panel is titled," Foreign Investments and the New GATT Round." They answered…